> SVR means "sustained viral response" - the key word is "sustained". SVR is
> only applicable a minimum of six months *after completion of therapy* and if
[quoted text clipped - 15 lines]
> treatment is not substantial enough to have a reasonable chance of SVR. That
> would be under 2log drop by the end of the 12th week.
>> SVR means "sustained viral response" - the key word is "sustained". SVR is
>> only applicable a minimum of six months *after completion of therapy* and if
[quoted text clipped - 21 lines]
>
>Wish ya could improve the odds...........
Don't we all. Unfortunately, to this point, the best that could be done is to
close the gap between "testing clear" and failing to achieve SVR, by
redefining the "testing clear" part.
It occurred to me this morning that what you were probably asking was
something to the effect of "if the patient is clear at 12 weeks how can he
still relapse after completing treatment?" And that's a good question.
The problem is in testing for "free-floating" virions in the blood stream
while the location of the viral replication "factories" is in the liver.
Considering all the products of the IFN-stimulated immune system are in the
blood stream, it isn't unreasonable to expect said blood will appear "cleaner"
than the infected liver tissue might.
But we don't do routine biopsies to do viral load testing - for obvious safety
reasons. Hence there is that disconnect between test procedures and the
actual state of infection. VL tests are thus reduced to "inference", which is
rarely 100% accurate, leaving plenty of room to appear "clear" even while some
viral replication factories remain.
Something Dr. Cecil speculates on might be a major contributor to this
uncertainty: it seems to have a relationship to the level of liver damage
present. Perhaps the virus can "hide" in the scar tissue, being less
vascularized than normal liver structure which in turn makes it less likely
that the immune system components floating along in the blood stream can come
in contact.
The same techniques that have been used to declare that there is an "occult
HCV infection" syndrome in a few studies ought to be tested to see if there is
a clinical use to help break down that level of disconnect between the
currently used VL test techniques and the actual state of infection.
I haven't looked into these techniques - which often claim to have found
virions within PBMCs (peripheral blood mononuclear cells) while standard VL
tests show "clear" - though I've often wondered what exactly is being tested
in a "normal" VL test if it misses virions in PBMCs. Clearly they don't put
whole blood into a Cuisinart and test the resulting goo ;-)
Cheers
/greyhackles
amzolt - 25 Oct 2007 11:25 GMT
> But we don't do routine biopsies to do viral load testing - for obvious safety
> reasons. Hence there is that disconnect between test procedures and the
> actual state of infection. VL tests are thus reduced to "inference", which is
> rarely 100% accurate, leaving plenty of room to appear "clear" even while some
> viral replication factories remain.
> Clearly they don't put
> whole blood into a Cuisinart and test the resulting goo ;-)
Thanks again for your ever-wise yet humorus advice and information!!
Gonna print this out and take it to my next TxTeam visit...